DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20210812

An observational study on prevalence and determinants of PCOS in women presenting with acne vulgaris to a tertiary care hospital in North India

Mini Chandra, Palak Garg, Koshinder Vats, Abhishek O. Tibrewal

Abstract


Background: Acne vulgaris is an inflammatory disease of pilosebaceous gland that usually affects people from puberty to young adulthood. Apart from being a dermatological condition, acne is now recognised to be related to a plethora of systemic disorders, notably endocrinal abnormalities, like Polycystic Ovarian Syndrome (PCOS). We conducted this study with the aim of finding the prevalence and determinants of PCOS among patients presenting with acne vulgaris.

Methods: In this prospective observational study, 100 women were selected who presented with acne, to the out-patient dermatology department of our hospital. The study subjects were 14 to 36 years old, non-pregnant females, who agreed to be a part of the study. PCOS was diagnosed using Rotterdam criteria. Statistical software (SPSS version 22) was used for the statistical analyses.

Results: Out of the 100 study subjects, 81 (81%) had PCOS and 19 (19%) did not. The subjects who had PCOS were older (Median of 22 years vs 20 years), higher FSH levels (Median of 5.8 vs 3.2), higher LH/FSH ratio (Median of 0.7 vs 0.6), and higher DHEA levels (Median of 285.5 vs 160.3), though these differences were not statistically significant. The PCOS group was more likely to be suffering from irregular menses (OR, 1.51; 95% CI: 0.5-4.5, p value 0.46), weight gain (OR, 1.02; 95% CI: 0.37-2.7, p value 0.97), and hirsutism (OR, 1.17; 95% CI: 0.43 - 3.24), as compared to the non-PCOS group. However, PCOS was not significantly associated with age, duration of acne, fasting blood sugar levels, HOMA-IR, or levels of hormones like FSH, LH, Testosterone, DHEA, and Insulin.

Conclusions: The study concludes a high prevalence of PCOS among acne patients. All women with acne should be considered for underlying PCOS and asked about their menstrual patterns and examined for other sign of hyperandrogenism.

 


Keywords


Acne vulgaris, Endocrinal disorder, Observational study, PCOS

Full Text:

PDF

References


Lyon CC. Acne: Diagnosis and Management. JR Soc Med. 2001;94(12):652.

Sutaria AH, Masood S, Schlessinger J. Acne Vulgaris. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 January. Available at https://www.ncbi.nlm.nih.gov/books/NBK459173/ Accessed on 12 September.

Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014;32(3):389-96.

Ozdemir S, Ozdemir M, Gorkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199-204.

Alan S, Cenesizoglu E. Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Med J. 2014;35(8):886-9.

O’Connell K. Pharmacology of hormonal contraceptives and acne. Cutis. 2008;81:8-12.

Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol. 2002;119(5):992-1007.

Raja SA, Prasad PVS, Kaviarasan PK. Prevalence and pattern of PCOS in women presenting with acne, a hospital based prospective observational study. Int J Res Med Sci. 2018;6:899-903.

Zaenglien AL, Graber EM, Thiboutet DM, Strauss JS. In: Wolff K, Goldsmith LA, Katz SI et al., editors. Fitzpatrck's Dermatology in General Medicine. 7 th ed. USA: McGraw Hill; 2008. Chapter 80: Acne vulgaris and acne form eruptions. 690-730.

Jacob R. Prevalence of acne among women with polycystic ovarian syndrome-a clinical study.SIRJ-HMS. 2014;1(1):7-11.

James WD, Berger TG, Elston DM, editors. Andrew's Disease of the Skin. 10th ed. Philadelphia: Saunders Company; 2006.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.

Batista, FAS, Paula A. Types of Acne and associated therapy. Am Research J. 2006;15:257–66.

Emiroğlu N, Cengiz FP, Kemeriz F. Insulin resistance in severe acne vulgaris. Postepy Dermatol Alergol. 2015;32(4):281-5.

Begum S, Hossain MZ, Rahman MF, Banu LA. Polycystic ovarian syndrome in women with acne. J Pak Association Dermatol. 2012;22(1):24-9.

Fraser IS, Kovacs G. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:813-23.

Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings. J Am Acad Dermatol. 2016;20(4):194-8.

Kelekci KH, Kelekci S, Incki K, Ozdemir O, Yilmaz B. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Int J Dermatol. 2010;49(7):775-9.

Abdullah Z, Masood Q, Hassan I, Kirmani O. Hormonal profile and polycystic ovaries in women with acne vulgaris. Ind J Dermatol Venereol Leprol. 2013;79(3):422-4.

Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol. 2010;9(2):142-8.

Betti R, Bencini PL, Lodi A, Urbani CE, Chiarelli G, Crosti C. Incidence of polycystic ovaries in patients with late-onset or persistent acne: hormonal reports. Dermatologica. 1990;181(2):109-11.

Tehrani M, Parvizi M, Moghadam AS, Heshmat R, Khas SNZ, Golchin M. The prevalence of polycystic ovary syndrome in Iranian women with gestational diabetes: a pilot study. Iranian J Diab Lipid Disorders. 2009:57-64.

Timpatanapong P, Rojanasakul A. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. J Dermatol. 1997;24:223-9.

Falsetti L, Gambera A, Andrico S, Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecol Endocrinol. 2002;16(4):275-84.

Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol. 2007;8(4):201-19.

Yu NE, Ho PC. Polycystic ovary syndrome in Asian women. Semin Reprod Med. 2008;26:14-21.